drugset / Trial / NCT07159126
A Study of DS3610a in Participants With Advanced Solid Tumor
Non-randomizedSequentialOpen-labelTreatment
Summary
This study is designed to assess the safety, tolerability, and efficacy of DS3610a, given as a single agent to participants with advanced or metastatic solid tumors.
Timeline
- Start
- 2025-10-09
- Primary completion
- 2028-09-01
- Completion
- 2031-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DS3610a | Unknown | — | — |